Claritev Class A (CTEV) closed at $28.67 on November 10, 2026, up 19.5% from the previous close, on volume of 923,598 shares (30-day average 230,841).
Data as of November 10, 2026.
Claritev (CTEV) Receives a Buy from Guggenheim
TipRanks (Tue, 10-Nov 7:29 AM ET)
Canaccord Genuity Sticks to Their Buy Rating for Claritev (CTEV)
TipRanks (Tue, 10-Nov 7:29 AM ET)
TipRanks (Tue, 10-Nov 6:30 AM ET)
Claritev GAAP EPS of -$3.64 misses by $0.01, revenue of $268.3M beats by $12.17M
Seeking Alpha News (Mon, 9-Nov 6:08 AM ET)
Claritev Corporation Reports Third Quarter 2026 Results
Globe Newswire (Mon, 9-Nov 6:00 AM ET)
Here are the major earnings before the open Monday
Seeking Alpha News (Sun, 8-Nov 6:04 PM ET)
Claritev Q3 2026 Earnings Preview
Seeking Alpha News (Fri, 6-Nov 1:00 PM ET)
Globe Newswire (Thu, 5-Nov 8:23 AM ET)
Globe Newswire (Thu, 29-Oct 10:30 AM ET)
Claritev Appoints Jennifer Main to its Board of Directors
Globe Newswire (Thu, 15-Oct 9:00 AM ET)
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The company's focus is on being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Claritev Class A trades on the NYSE stock market under the symbol CTEV.
As of November 10, 2026, CTEV stock price climbed to $28.67 with 923,598 million shares trading.
CTEV has a beta of 2.42, meaning it tends to be more sensitive to market movements. CTEV has a correlation of 0.04 to the broad based SPY ETF.
CTEV has a market cap of $485.88 million. This is considered a Small Cap stock.
Last quarter Claritev Class A reported $268 million in Revenue and -$3.64 earnings per share. This beat revenue expectation by $12 million and missed earnings estimates by -$4.27.
The top ETF exchange traded funds that CTEV belongs to (by Net Assets): VTI, IWM, VXF, IWN, FNDA.
CTEV has underperformed the market in the last year with a return of -58.6%, while the SPY ETF gained +12.9%. In the last 3 month period, CTEV fell short of the market, returning -12.0%, while SPY returned -2.8%. However, in the most recent 2 weeks CTEV has outperformed the stock market by returning +33.1%, while SPY returned -2.0%.
CTEV support price is $22.62 and resistance is $25.38 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CTEV shares will trade within this expected range on the day.
